AI-Powered Surgical Value Intelligence
Hospitals have had no leverage to change surgeon behavior — and surgeons have had no reason to take responsibility for cost. Metreon cracks that code. We translate chaotic, siloed OR data into a risk-adjusted, outcome-connected language that aligns surgeon and hospital incentives for the first time.
Metreon is the translator between surgical cost data and clinical value. We turn chaotic numbers into a language both surgeons and hospitals act on — aligning incentives for the first time.
The Problem
Hospitals are inundated with surgical cost data — supply spend, implant invoices, preference cards, case logs, charge capture. The data exists. What doesn't exist is a way to interpret it. Cost in isolation means nothing. If you get value from spending money, that's fine — but how do you know?
The data is chaotic, siloed from outcomes, and disconnected across cost centers. Holistic cost savings transcend any single department — surgeons know this intuitively. Administrators often ignore it. Existing cost-reduction efforts rely on top-down enforcement that surgeons don't trust because the data doesn't speak their language.
No risk-adjusted, outcome-connected, portable credential exists for surgical efficiency. Without transparency and professional identity stake, there is no lasting change.
The clinical evidence is unambiguous: higher supply cost shows no association with improved patient outcomes. Adjusted odds ratio for 30-day readmission: AOR 1.03 (95% CI 0.97–1.09). Cost is not a proxy for quality — it is an unmanaged variable that needs context, risk adjustment, and connection to outcomes.
Hospitals have mountains of OR data — but no tool translates it into a language that connects cost to outcomes across cost centers. The data exists. The interpretation doesn't.
Cost reports built for finance mean nothing at the scrub table. Without risk adjustment and outcome context, surgeons rightly dismiss the numbers as incomplete.
Money spent isn't the problem — money spent without knowing whether it produced value is. Holistic savings transcend individual cost centers, but no tool connects them.
Without a transparent, risk-adjusted, portable measure of efficiency that surgeons own, there is no professional stake in cost data — and every reason to ignore it.
The Solution
Underneath Metreon is a rigorous statistical scaffolding — multilevel risk adjustment, case-mix modeling, peer-cohort benchmarking. But numbers alone just create a new flood of data no one acts on.
Metreon's AI layer translates every metric, score, and benchmark into natural language that surgeons and administrators actually understand. Ask any question. Get a plain-English explanation of what your data means, why it matters, and what to do about it. No statistical training required.
A risk-adjusted efficiency score for individual surgeons, scaled 300–850. Accounts for case mix, patient acuity, and procedure complexity. Portable across institutions. Owned by the surgeon.
Surgeons and administrators see exactly the same data — no hidden views, no surveillance architecture. The score becomes a professional credential, not a compliance hammer. Every metric includes an AI-generated plain-language interpretation so the data speaks for itself.
An operating system for OR cost intelligence. Surfaces surgeon-level and service-line-level supply cost variation with AI-powered interpretation that turns data into decisions.
Every report comes with a natural language narrative — not just charts. Administrators get AI-generated action recommendations and plain-English explanations of statistical findings. Integrates with existing EMR and revenue cycle infrastructure.
How It Works
Activates on minimum viable dataset in weeks. EHR-agnostic. Every methodology disclosed.
See It In Action
Walk through the same screens hospital administrators and surgeons see. Toggle between roles, advance through feature phases, and experience the behavioral architecture firsthand.
Your risk-adjusted efficiency credential (300-850), AI-interpreted performance trends, peer benchmarks, and dispute pathway. Fully open — no login required.
Coming SoonSystem-wide cost opportunity with AI-generated narratives, surgeon engagement tiers, data confidence scoring, and billing integrity. Overview is open; deeper analytics prompt a conversation.
Coming SoonFree surgeon platform: CV builder, PubMed integration, Conference Hub, peer connections, hospital quality profiles, and verified forum. The viral acquisition layer that pulls hospitals toward activation.
Coming Soon30 screens across three personas. De-identified synthetic data. Use Demo Controls to toggle phases and states.
Pilot Partnerships
Metreon is currently in development with an academic health system pilot site. We are seeking 2–3 additional forward-thinking health systems for inaugural deployment — institutions that believe surgical efficiency is a solvable problem and are ready to lead.
Pilot partners receive dedicated onboarding, co-development input on analytics priorities, and preferred partnership terms. Health investors are also invited to connect.
A conversation focused on partnership fit, not sales.
About
Metreon AI, Inc. is a Delaware C-corporation founded in 2026 by a team of surgeons, operators, and engineers. We built the translator that was missing — because measurement without trust is just another mandate, and ownership is what drives change.
Vice Chair of Surgery and Chief Quality Officer at a major academic medical center. Practicing surgeon and national research leader in the field of surgical outcomes and healthcare value.
Founder and President of Funwares, a consumer products company built and operated across US and Hong Kong markets for over two decades. A UC Berkeley-trained attorney turned operator, Rob brings cross-functional experience in product development, manufacturing, and commercial scaling to Metreon's go-to-market execution.
Former CEO of Velodyne Lidar and founder of Vayu Robotics, acquired by Nasdaq-listed Serve Robotics. A technology entrepreneur with two decades of leadership across AI, robotics, and semiconductor systems, Anand brings deep experience scaling technical organizations from early innovation through public listing and acquisition.
Metreon is currently in pilot development with an anchor academic health system. We are actively seeking partnerships with forward-thinking hospital systems and health investors who believe that surgical efficiency is a solvable problem and are prepared to act on it.
Contact
Whether you're a hospital leader, surgeon, or investor — we'd like to hear from you.
We'll be in touch within one business day.
Or reach us directly at contact@metreon.ai